These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 16509924
1. Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure. Eleftheriadis T, Antoniadi G, Liakopoulos V, Tsiandoulas A, Barboutis K, Stefanidis I. Nephrology (Carlton); 2006 Feb; 11(1):3-8. PubMed ID: 16509924 [Abstract] [Full Text] [Related]
5. [Initial experience with use of cationic propyl gallate as an inducer of thrombocyte aggregation in evaluation of anti-aggregation therapy]. Petrzelová A, Stejskal D, Prosková J, Oral I, Dostálová S, Lacnák B, Sebecková I, Horalík D, Zapletalová J, Bartek J, Vecerová H. Vnitr Lek; 2001 Nov; 47(11):747-52. PubMed ID: 11795179 [Abstract] [Full Text] [Related]
6. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment. Stasko J, Galajda P, Ivanková J, Hollý P, Rozborilová E, Kubisz P. Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193 [Abstract] [Full Text] [Related]
7. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis. Burmeister JE, Scapini A, da Rosa Miltersteiner D, da Costa MG, Campos BM. Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314 [Abstract] [Full Text] [Related]
8. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin. Sagedal S, Hartmann A, Osnes K, Bjørnsen S, Torremocha J, Fauchald P, Kofstad J, Brosstad F. Nephrol Dial Transplant; 2006 Feb; 21(2):444-9. PubMed ID: 16234293 [Abstract] [Full Text] [Related]
10. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation]. Myśliwiec M, Popławski A, Soszka J. Pol Tyg Lek; 2006 Feb; 46(4-5):76-8. PubMed ID: 1845699 [Abstract] [Full Text] [Related]
11. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis. Leithner C, Sinzinger H, Silberbauer K, Stummvoll HK. Proc Eur Dial Transplant Assoc; 1981 Feb; 18():122-5. PubMed ID: 7036146 [Abstract] [Full Text] [Related]
16. Influence of haemodialysis on early markers of atherosclerosis. Kovacic V, Ljutic D, Dodig J, Radic M, Duplancic D. Nephrology (Carlton); 2008 Dec; 13(6):472-9. PubMed ID: 18518941 [Abstract] [Full Text] [Related]
17. [Effects of L-carnitine on erythropoiesis and blood platelet aggregation in patients with chronic renal failure treated with hemodialysis]. Kalinowski M, Popławski A, Mazerska M, Daniluk A. Pol Merkur Lekarski; 1999 Feb; 6(32):76-8. PubMed ID: 10337176 [Abstract] [Full Text] [Related]
18. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration. Christidou F, Bamichas G, Galaktidou G, Fragidis S, Gionanlis L, Frangia T, Bischiniotis T, Sombolos K. Ren Fail; 2008 Feb; 30(9):861-4. PubMed ID: 18925524 [Abstract] [Full Text] [Related]
19. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis. Liberek T, Renke M, Skonieczny B, Kotewicz K, Kowalewska J, Chmielewski M, Kot J, Lichodziejewska-Niemierko M, Rutkowski B. Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418 [Abstract] [Full Text] [Related]